Article Text

Short report
Stay at home: implementation and impact of virtualising cancer genetic services during COVID-19
Free
  1. Maia Leigh Norman1,2,
  2. Janet Malcolmson1,
  3. Susan Randall Armel1,3,
  4. Brittany Gillies1,
  5. Brian Ou1,
  6. Emily Thain1,
  7. Jeanna Marie McCuaig1,3,
  8. Raymond H Kim1,4
  1. 1Familial Cancer Clinic, University Health Network, Toronto, Ontario, Canada
  2. 2Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada
  3. 3Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
  4. 4Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  1. Correspondence to Dr Raymond H Kim, Familial Cancer Clinic, University Health Network, Toronto, ON M5T 3L9, Canada; Raymond.Kim{at}uhn.ca

Abstract

The COVID-19 pandemic has led to the rapid adoption of virtual clinic processes and healthcare delivery. Herein, we examine the impact of virtualising genetics services at Canada’s largest cancer centre. A retrospective review was conducted to evaluate relevant metrics during the 12 weeks prior to and during virtual care, including referral and clinic volumes, patient wait times and genetic testing uptake. The number of appointments and new patients seen were maintained during virtual care. Likewise, there was a significant increase in the number of patients offered testing during virtual care who did not provide a blood sample (176/180 (97.7%) vs 180/243 (74.1%); p<0.001), and a longer median time from the date of pretest genetic counselling to the date a sample was given (0 vs 11 days; p<0.001). Referral volumes significantly decreased during virtual care (35 vs 22; p<0.001), which was accompanied by a decreased median wait time for first appointment (55 days vs 30 days; p<0.001). The rapid virtualisation of cancer genetic services allowed the genetics clinic to navigate the COVID-19 pandemic without compromising clinical volumes or access to genetic testing. There was a decrease in referral volumes and uptake of genetic testing, which may be attributable to pandemic-related clinical restrictions.

  • genetic counseling
  • genetics
  • medical
  • genetics
  • genetic testing
  • human genetics

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage
View Full Text

Statistics from Altmetric.com

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Footnotes

  • Twitter @Maia__Norman

  • Contributors MLN: conceptualisation; data curation; formal analysis; investigation; methodology; project administration; visualisation; writing (original draft, review, editing). JM: conceptualisation; data curation; formal analysis; investigation; methodology; project administration; visualisation; writing (review, editing). SRA: conceptualisation; supervision; writing (review, editing). BG: conceptualisation; methodology; writing (review, editing). BO: investigation; writing (review, editing). ET: conceptualisation; writing (review, editing). JM: conceptualisation; data curation; formal analysis; methodology; writing (review, editing). RHK: conceptualisation; funding acquisition; methodology; supervision; writing (review, editing).

  • Funding This manuscript was made possible through the support of The Bhalwani Family Charitable Foundation to RHK.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval This study has been approved by the University Health Network (UHN) Research Ethics Board (PMH-UHN REB 20–5428).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.